Latest News
The Waikato Breast Cancer Research Trust (WBCRT) is seeking participants with moderately severe treatment-resistant lymphoedema for this research. Is lymphoedema of your arm an ongoing problem for you? Have you undergone at least three months of lymphoedema therapy? If so, you may be eligible for this trial.
Key findings announced at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago include breakthroughs in the treatment of breast cancer and research. In a series of articles including this one, we outline some of the exciting developments reported.
Women who give so much to their families and communities now need help from the community to contribute to funding the medicines they need to treat their advanced breast cancer. These medicines help extend lives and improve quality of life. They are listed in international guidelines as the treatments that should be provided and they are funded across the developed world, but they are not funded in New Zealand.
We are thrilled that Lachlan McKenzie (38) has decided to run his first marathon for BCAC. Lachlan’s mum, Julie Bunnell, has advanced breast cancer, and Lachlan is running for BCAC because of the support we give women like her.
To donate: go to Lachlan's Marathon for Advanced Breast Cancer givealittle page. Please donate for Lachlan's fundraising campaign via this link rather than the donation buttons on this page. Lachlan wants to keep track of how much money he raises for us.
Media Release of the Breast Cancer Aotearoa Coalition and Lung Foundation New Zealand
BCAC and Lung Foundation NZ media release, 3 May 2019
BCAC and Lung Foundation NZ media release, 30 April 2019
Health advocacy groups and individuals will present strongly worded petitions to Parliament on 7 May demanding proper funding of medicines.
Breast Cancer Aotearoa Coalition media release, 23 April 2019: PHARMAC has refused funding for Kadcyla, an important drug that has recently had a high media and public profile.
Media release: A powerful group of women will be speaking at the Health Select Committee on 13 and 20 March to describe how traumatic it is for them to know that medicines that would give them longer lives aren’t approved for funding in New Zealand.
In an exciting breakthrough, a very important protein has been discovered that predicts whether a breast cancer patient is going to respond successfully to endocrine therapy or chemotherapy.
A tool based on the protein is now being developed, to enable clinicians to make more precise and reliable decisions about treatment.
